Xponance’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.3K | Buy |
21,195
+1,333
| +7% | +$1.65K | ﹤0.01% | 1488 |
|
|
2025
Q1 | $23.4K | Buy |
19,862
+468
| +2% | +$552 | ﹤0.01% | 1418 |
|
|
2024
Q4 | $35.5K | Buy |
19,394
+1,148
| +6% | +$2.1K | ﹤0.01% | 1412 |
|
|
2024
Q3 | $31K | Buy |
18,246
+652
| +4% | +$1.11K | ﹤0.01% | 1366 |
|
|
2024
Q2 | $24.1K | Buy |
17,594
+2,249
| +15% | +$3.08K | ﹤0.01% | 1303 |
|
|
2024
Q1 | $57.5K | Buy |
15,345
+53
| +0.3% | +$199 | ﹤0.01% | 1271 |
|
|
2023
Q4 | $150K | Buy |
15,292
+200
| +1% | +$1.96K | ﹤0.01% | 1187 |
|
|
2023
Q3 | $126K | Buy |
15,092
+267
| +2% | +$2.23K | ﹤0.01% | 1152 |
|
|
2023
Q2 | $197K | Buy |
14,825
+690
| +5% | +$9.18K | ﹤0.01% | 1148 |
|
|
2023
Q1 | $164K | Buy |
14,135
+1,230
| +10% | +$14.2K | ﹤0.01% | 1137 |
|
|
2022
Q4 | $106K | Buy |
12,905
+163
| +1% | +$1.33K | ﹤0.01% | 1152 |
|
|
2022
Q3 | $74K | Buy |
12,742
+532
| +4% | +$3.09K | ﹤0.01% | 1124 |
|
|
2022
Q2 | $54K | Buy |
+12,210
| New | +$54K | ﹤0.01% | 1151 |
|
|
2021
Q4 | – | Sell |
-9,131
| Closed | -$233K | – | 1189 |
|
|
2021
Q3 | $233K | Sell |
9,131
-1,517
| -14% | -$38.7K | ﹤0.01% | 1093 |
|
|
2021
Q2 | $372K | Buy |
+10,648
| New | +$372K | 0.01% | 1015 |
|